Class ITerminatedD-1250-2014
Drug recall · April 30, 2014
XIYOUJI QINGZHI CAPSULE recall
Why: Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box
- Lots / codes
All Lots
- Quantity
- 8 bottles
- Company
- Dolphin Intertrade Corporation, Miami, FL
- Distribution
- Nationwide
- Initiated
- May 20, 2013 · Voluntary: Firm initiated
- Classified
- April 18, 2014
- Reported
- April 30, 2014
- Ended
- June 29, 2016
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.